Recombinant Rabbit Substance-K receptor (TACR2)

What is the Substance-K receptor (TACR2) and what is its primary function?

The Substance-K receptor, also known as TACR2 or NK2R, is a receptor for the tachykinin neuropeptide substance K (neurokinin A). It belongs to the G protein-coupled receptor (GPCR) family, specifically within the tachykinin receptor subfamily. TACR2 is associated with G proteins that activate a phosphatidylinositol-calcium second messenger system . The receptor's primary function involves mediating the biological effects of neurokinin A, including smooth muscle contraction, neuronal excitation, and inflammatory responses.

The receptor demonstrates a specific rank order of affinity for tachykinin peptides: substance K (neurokinin A) > neuromedin-K > substance P . This binding specificity determines its physiological role and pharmacological profile.

What is the molecular structure of rabbit TACR2?

Rabbit TACR2 exhibits the typical GPCR architecture with seven transmembrane domains (TM1-TM7) connected by alternating intracellular loops (ICL1-3) and extracellular loops (ECL1-3) . The protein begins with an N-terminal extracellular domain and concludes with a C-terminal intracellular domain. The amino acid sequence reveals conserved motifs characteristic of Class A GPCRs, particularly those in the tachykinin receptor family.

Key structural features include:

• N-terminal domain consisting of approximately 30 amino acids

• Seven hydrophobic transmembrane domains that anchor the receptor in the cell membrane

• Three extracellular loops that contribute to ligand binding specificity

• Three intracellular loops involved in G protein coupling and signal transduction

• C-terminal domain involved in receptor regulation and trafficking

What are the known synonyms and identifiers for rabbit TACR2?

When searching literature and databases, researchers should be aware of the various nomenclature used for rabbit TACR2. The following synonyms and identifiers are commonly used :

• TACR2 (gene name)

• TAC2R (alternative gene name)

• NK2R (common abbreviation)

• Neurokinin 2 receptor

• NK-2 receptor

• NK-2R

• Neurokinin A receptor

• Substance-K receptor

• SK receptor

• SKR

• Substance K receptor

• NKNAR

• Tachykinin receptor 2

What expression systems are most effective for producing recombinant rabbit TACR2?

The choice of expression system for rabbit TACR2 significantly impacts protein yield, functionality, and post-translational modifications. Based on research practices with similar GPCRs, the following expression systems offer distinct advantages:

For functional studies and accurate pharmacological characterization, mammalian expression systems are generally preferred as they provide the most physiologically relevant environment for TACR2.

What are critical considerations for designing recombinant rabbit TACR2 constructs?

When designing constructs for recombinant rabbit TACR2 expression, researchers should address several factors to optimize expression and functionality:

• Codon optimization: Adapt the nucleotide sequence to the preferred codon usage of the expression host while avoiding rare codons that might reduce translation efficiency.

• Signal peptide selection: The native signal peptide may be replaced with well-characterized alternatives (e.g., hemagglutinin signal peptide) to enhance membrane targeting in heterologous systems.

• Affinity tags and fusion partners:

  • N-terminal tags may interfere with signal peptide cleavage

  • C-terminal tags are generally preferred for GPCRs but may affect G protein coupling

  • Common tags include His6, FLAG, and HA

  • Fusion partners like BRIL, T4 lysozyme, or GFP can enhance expression or stability

• Potential modifications to enhance expression:

  • Removal of predicted proteolytic sites

  • Introduction of thermostabilizing mutations based on alanine scanning

  • Deletion or modification of flexible regions that may cause aggregation

  • Codon optimization for the expression host

• Expression vector selection: Consider promoter strength, selection markers, and regulatory elements appropriate for the chosen expression system.

How can recombinant rabbit TACR2 be used in binding assays to characterize novel ligands?

Recombinant rabbit TACR2 provides a controlled system for characterizing the binding properties of novel ligands through various experimental approaches:

When designing binding experiments with rabbit TACR2, researchers should consider:

• Receptor expression level and homogeneity

• Membrane preparation quality or cell viability

• Buffer composition (pH, ionic strength, reducing agents)

• Incubation temperature and equilibration time

• Controls for non-specific binding

• Data analysis using appropriate mathematical models

What functional assays are appropriate for characterizing signal transduction through recombinant rabbit TACR2?

Since TACR2 primarily couples to G proteins that activate phosphatidylinositol-calcium signaling pathways , several functional assays can be employed to measure receptor activation:

For comprehensive characterization, combining multiple assays targeting different aspects of signal transduction provides the most complete understanding of receptor pharmacology.

How should researchers approach structure-function studies of rabbit TACR2?

Structure-function studies of rabbit TACR2 require systematic modification of the receptor and evaluation of the functional consequences. Effective approaches include:

• Sequence-based targeting:

  • Align rabbit TACR2 with other species and tachykinin receptor subtypes

  • Identify conserved motifs and divergent regions

  • Target highly conserved residues for mutagenesis to identify critical functional elements

  • Focus on divergent residues to understand subtype or species specificity

• Structure-guided approaches:

  • Generate homology models based on related GPCR crystal structures

  • Identify residues in predicted binding pockets

  • Target residues in G protein interaction interfaces

  • Focus on regions involved in conformational changes during activation

• Systematic mutagenesis strategies:

  • Alanine scanning of transmembrane domains

  • Conservative substitutions to probe specific chemical interactions

  • Chimeric receptors swapping domains between related receptors

  • Domain deletion or insertion to test structural elements

• Experimental validation combining:

  • Ligand binding assays to assess affinity changes

  • Functional assays to assess signaling alterations

  • Surface expression measurements to confirm proper folding and trafficking

  • Conformational studies using intramolecular sensors or accessibility measurements

How can rabbit TACR2 be used to investigate species differences in tachykinin pharmacology?

Species differences in TACR2 pharmacology provide valuable insights for translational research. Rabbit TACR2 serves as an important comparative model due to its distinct pharmacological profile:

• Comparative sequence analysis:

  • Alignment of rabbit TACR2 with human, mouse, and other species reveals key differences

  • Identification of species-specific amino acids in binding domains

  • Evolutionary conservation analysis highlights functionally important residues

  Species	Sequence Identity with Rabbit TACR2	Key Divergent Regions	Pharmacological Implications
  Human	~85%	ECL2, TM5	Differences in antagonist binding
  Mouse	~82%	N-terminus, ECL3	Altered selectivity for certain peptides
  Rat	~83%	ICL3, C-terminus	Differences in signaling efficiency
  Guinea Pig	~87%	ECL2, TM7	Closest pharmacological profile to rabbit

• Comparative pharmacology approaches:

  • Parallel testing of ligand panels across species orthologs

  • Identification of species-selective compounds

  • Characterization of differences in signaling bias between species

• Chimeric receptor studies:

  • Swapping domains between rabbit and human TACR2

  • Identifying regions responsible for species-specific pharmacology

  • Creating humanized rabbit receptors for translational research

• Application to drug discovery:

  • Prediction of human responses based on multi-species profiling

  • Understanding evolutionary conservation of binding sites

  • Identification of species-conserved effects more likely to translate to humans

What approaches are available for studying TACR2 dimerization or oligomerization?

GPCR dimerization can significantly impact receptor pharmacology and function. For rabbit TACR2, several complementary approaches can assess potential oligomerization:

• Biophysical techniques:

  • Resonance energy transfer methods (BRET/FRET)

  • Single-molecule imaging and tracking

  • Fluorescence recovery after photobleaching (FRAP)

  • Time-resolved FRET with labeled antibodies against epitope tags

• Biochemical approaches:

  • Chemical cross-linking followed by immunoprecipitation

  • Blue native PAGE to preserve protein complexes

  • Proximity ligation assays in native tissues

  • Co-immunoprecipitation with differentially tagged receptors

• Functional validation:

  • Dominant-negative constructs to disrupt function

  • Trans-complementation between binding-deficient and signaling-deficient mutants

  • Bivalent ligands targeting dimeric receptors

  • Allosteric modulation through dimer interfaces

• Computational prediction:

  • Molecular dynamics simulations of receptor interactions

  • Analysis of potential dimerization interfaces

  • Energy calculations for stability of dimer formations

When designing these experiments, researchers should consider several critical factors:

• Expression levels that avoid artificial aggregation

• Controls for non-specific interactions

• Methods to distinguish between dimerization and clustering

• Validation in multiple systems including native tissues

How can recombinant systems help resolve contradictory findings in TACR2 signaling?

Contradictory findings in TACR2 signaling research can arise from multiple factors. Recombinant systems offer controlled environments to systematically investigate discrepancies:

• Expression level standardization:

  • Titrated expression using inducible promoters

  • Quantification of receptor density by radioligand binding

  • Single-cell analysis to account for heterogeneous expression

  • Comparison with physiological expression levels

• Defined cellular backgrounds:

  • Use of cells lacking endogenous tachykinin receptors

  • Knockout of specific signaling components to determine requirements

  • Reconstitution of signaling pathways in simplified systems

  • Comparison across multiple cell backgrounds

• Temporal resolution of signaling:

  • Real-time measurements of multiple signaling outputs

  • Comparison of acute vs. sustained responses

  • Investigation of desensitization and internalization kinetics

  • Analysis of signaling adaptation over different time scales

• Systematic protocol comparison:

  • Standardization of buffer conditions, temperature, and other variables

  • Side-by-side comparison of different assay methodologies

  • Round-robin testing across different laboratories

  • Development of standard operating procedures

When addressing contradictions, researchers should develop experimental designs that specifically test competing hypotheses while controlling for variables that might explain discrepancies in previous studies.

What quality control measures are essential when working with recombinant rabbit TACR2?

Rigorous quality control is critical for ensuring reliable results with recombinant TACR2:

• Molecular validation:

  • Sequence verification of expression constructs

  • Restriction enzyme digestion patterns

  • Stability of the construct during cell propagation

  • Absence of unwanted mutations or recombination events

• Expression validation:

  • Western blotting to confirm expression at expected molecular weight

  • Flow cytometry to assess surface expression levels

  • Immunofluorescence microscopy to verify cellular localization

  • Quantitative PCR to measure transcript levels

• Functional validation:

  • Binding of reference ligands with expected affinity

  • Dose-response curves with appropriate EC50/IC50 values

  • Expected signaling in response to known agonists

  • Appropriate antagonist blockade

  • Comparison with published parameters for rabbit TACR2

• Stability assessment:

  • Consistent expression over passage number

  • Reproducible functional responses over time

  • Storage stability of membrane preparations

  • Freeze-thaw stability for preserved samples

• System-specific validations:

  • For purified receptor: homogeneity by size exclusion chromatography

  • For stable cell lines: clonality and expression uniformity

  • For transient transfections: transfection efficiency and expression window

How should researchers address potential artifacts in rabbit TACR2 studies?

Several artifacts can confound studies with recombinant TACR2. Researchers should implement specific controls and considerations:

• Expression-related artifacts:

  • Compare multiple expression levels to identify overexpression effects

  • Use inducible systems to compare different expression conditions

  • Include wild-type (untransfected) cells as negative controls

  • Compare with native tissues expressing TACR2 when possible

• Tag and fusion protein concerns:

  • Compare tagged and untagged versions to assess tag interference

  • Place tags at different positions to determine optimal placement

  • Use multiple tag types to confirm findings aren't tag-specific

  • Control for potential dimerization induced by fluorescent protein tags

• Cell background influences:

  • Test multiple cell backgrounds to identify cell-specific effects

  • Characterize endogenous signaling components in chosen cell lines

  • Consider knockout or knockdown of potential interfering proteins

  • Document the complete cellular context of experiments

• Technical artifacts:

  • Include appropriate vehicle controls for all reagents

  • Control for ligand stability under experimental conditions

  • Verify compound solubility and avoid precipitation

  • Test for direct effects of compounds on assay readouts

  • Include positive controls for assay functionality

• Validation approaches:

  • Confirm key findings with orthogonal assay methodologies

  • Perform concentration-response curves rather than single concentrations

  • Include time-course analyses for signaling responses

  • Use multiple reference compounds to calibrate the system

What approaches can resolve conflicting pharmacological data for rabbit TACR2?

When faced with conflicting pharmacological data regarding rabbit TACR2, researchers should:

• Implement systematic pharmacological analysis:

  • Full concentration-response curves rather than single-point measurements

  • Determination of both potency (EC50/IC50) and efficacy parameters

  • Use of multiple reference compounds for system calibration

  • Application of the operational model of agonism to determine coupling efficiency

  • Analysis of competitive vs. non-competitive antagonism

• Consider signaling bias:

  • Parallel measurement of multiple signaling pathways

  • Calculation of bias factors using appropriate reference ligands

  • Time-course analysis to capture temporal aspects of signaling

  • Integration of immediate and downstream responses

• Account for experimental variables:

  • Buffer composition effects (particularly calcium and magnesium concentrations)

  • Temperature sensitivity of binding and signaling

  • Receptor reserve effects in different expression systems

  • Ligand solubility and stability in assay conditions

• Statistical rigor:

  • Appropriate sample size based on power calculations

  • Blinded experimental design where possible

  • Technical and biological replicates

  • Robust statistical methods appropriate for the data structure

• Transparent reporting:

  • Complete methodology description for reproducibility

  • Sharing of raw data when possible

  • Acknowledgment of limitations and potential confounds

  • Consideration of alternative interpretations of the data